Axicabtagene ciloleucel

Axicabtagene ciloleucel is a type of advanced cancer treatment known as CAR T-cell therapy. It involves modifying a patient's own immune cells (T-cells) in a laboratory to better recognize and attack cancer cells, specifically for certain types of lymphoma. Once engineered, these cells are infused back into the patient, where they seek out and destroy cancer cells. This personalized immunotherapy can be highly effective for patients with relapsed or resistant lymphoma, offering a targeted approach that harnesses the body's immune system to fight cancer more effectively.